CARE-HF LTFU: CArdiac REsynchronization in Heart Failure Long-term Follow-up

NCT00318357 COMPLETED Results posted

The CARE-HF long-term follow-up trial evaluates the effects of cardiac resynchronization (CR) therapy on the mortality of patients from the CARE-HF program for an additional 4 year follow-up. Investigators are free to choose whatever available treatment they believe is in the patient's best interest.

Details

Lead sponsor	Medtronic Cardiac Rhythm and Heart Failure
Status	COMPLETED
Enrolment	309
Start date	2006-09
Completion	2010-09

Conditions

• Heart Failure

Interventions

• Continuation of CRT
• Upgrade to CRT

Primary outcomes

• All Cause Mortality — 8-year
  Long-term mortality with cardiac resynchronization therapy in the Cardiac Resynchronization-Heart Failure (CARE-HF) trial. The patients that were still alive after closure of the CARE-HF study (2005,NCT00170300), that were willing to participate in the CARE-HF LTFU study continued additional follow-up for 4 years, till end 2009. The reported mortality data is the combined mortality of the CARE-HF and the CARE-HF LTFU study. Study start CARE-HF 2000.

Countries

United Kingdom